EUVIMEDEUVIMED entdecken
Crossref

Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma

Jiahui Lu, Tinghuang Zhang, Chenying Jiang, Hongtao Hu, Yunxuan Fei, Yaqin Yang, Hai An, Haixin Qin, Zhihui Zhu, Yanzi Yang, Shasha Tian, Lili Huang und 1 weitere

International Immunopharmacology · 2025-08 · 161 · 114989

DOI: 10.1016/j.intimp.2025.114989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-08. Verfasst von Jiahui Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tumor-Associated Macrophages, Lanosterol. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Zhejiang Traditional Chinese Medicine Administration, National Natural Science Foundation of China, Traditional Chinese Medicine of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The tumor microenvironment (TME) plays a crucial role in cancer progression, with tumor-associated macrophages (TAMs) constituting the core cell population of the tumor immune microenvironment. TAMs can differentiate into M1 or M2 types based on the TME, either inhibiting or promoting tumor development. Ganoderma lucidum, a medicinal and edible fungus, has a long history of use for extending lifespan and improving health. Ganoderic acid A (GAA), a bioactive compound extracted from G. lucidum, is considered the most abundant monomer among ganoderic acids and has wide applications in clinical anti-tumor therapies. METHODS: In this study, the effects of GAA against hepatocellular carcinoma (HCC) by modulating TAMs were investigated. The orthotopic and subcutaneous HCC mouse models were established and administrated with GAA at doses of 30 mg/kg/day and 60 mg/kg/day. Additionally, the toxicity of GAA towards tumor cells and macrophages in vitro at concentrations ranging from 25 to 100 μM were evaluated and the phagocytic capacity of macrophages against HCC cells were assessed. The polarization of macrophages was analyzed, along with the expression of CSF1R. RESULTS: Our data demonstrated that GAA could suppress the growth of both orthotopic and subcutaneous HCC, which was closely associated with macrophage modulation, confirming that its anti-HCC activity was mediated by enhancing macrophage efficacy. GAA exhibited no significant toxicity to tumor cells and macrophages in vitro while enhancing the phagocytic capacity of macrophages against HCC cells. Furthermore, GAA promoted M1 polarization of macrophages while inhibiting M2 polarization. These effects were mechanistically linked to the suppression of CSF1R expression on macrophages, both in vivo and in vitro. CONCLUSION: Our findings suggest that GAA exerts immunotherapeutic effects in HCC by regulating macrophage polarization through CSF1R inhibition. As a promising natural bioactive compound with the potential to modulate the TME of HCC, GAA may provide novel insights into HCC immunotherapy through the reprogramming of TAMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsTumor-Associated MacrophagesLanosterolReceptors, Granulocyte-Macrophage Colony-Stimulating FactorAnimalsHumansMiceTumor MicroenvironmentCell Line, TumorMice, Inbred BALB CMaleImmunotherapyPhagocytosisHeptanoic AcidsReceptor, Macrophage Colony-Stimulating Factor

Stichwörter der Autor:innen

Colony stimulating factor 1 receptor (CSF1R)Ganoderic acid A (GAA)Hepatocellular carcinoma (HCC)Immune therapyTumor associated macrophages (TAMs)

Substanzen

ganoderic acid ALanosterolReceptors, Granulocyte-Macrophage Colony-Stimulating FactorCSF1R protein, humanHeptanoic AcidsReceptor, Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China.
  • Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
  • Hangzhou Third People's Hospital, Hangzhou, Zhejiang 310009, China.
  • School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311402, China; Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China. Elect…

Förderung

  • Zhejiang Traditional Chinese Medicine Administration
  • National Natural Science Foundation of China
  • Traditional Chinese Medicine of Zhejiang Province
  • Zhejiang Province Natural Science Foundation
  • Zhejiang Chinese Medical University

Zitieren

APA

Lu, J., Zhang, T., Jiang, C., Hu, H., Fei, Y., Yang, Y., An, H., Qin, H., Zhu, Z., Yang, Y., Tian, S., Huang, L., & Zhao, H. (2025). Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma. International Immunopharmacology, 161, 114989. https://doi.org/10.1016/j.intimp.2025.114989

Vancouver

Lu J, Zhang T, Jiang C, Hu H, Fei Y, Yang Y, et al. Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma. International Immunopharmacology. 2025;161:114989. doi:10.1016/j.intimp.2025.114989

BibTeX
@article{Lu2025,
  author = {Lu, Jiahui and Zhang, Tinghuang and Jiang, Chenying and Hu, Hongtao and Fei, Yunxuan and Yang, Yaqin and An, Hai and Qin, Haixin and Zhu, Zhihui and Yang, Yanzi and Tian, Shasha and Huang, Lili and Zhao, Huajun},
  title = {Ganoderic acid A regulates CSF1R to reprogram tumor-associated macrophages for immune therapy of hepatocellular carcinoma},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {161},
  pages = {114989},
  doi = {10.1016/j.intimp.2025.114989}
}
Kostenlos starten →